ZEVRA THERAPEUTICS, INC. — Investor Relations & Filings
Filings indexed
829
across all filing types
Latest filing
2026-05-06
Interim / Quarterly Rep…
Country
US
United States of America
Listing
US
ZVRA
Zevra Therapeutics, Inc. is a commercial-stage biopharmaceutical company dedicated to developing and commercializing therapies for patients with rare diseases. The company focuses on addressing significant unmet medical needs by combining a data-driven scientific approach with a patient-first perspective. Its portfolio includes commercial products such as MIPLYFFA®, an FDA-approved treatment for Niemann-Pick disease type C (NPC), and OLPRUVA®. Zevra Therapeutics also maintains a late-stage clinical pipeline, specializing in advancing promising medicines that face complex clinical and regulatory challenges for conditions with limited or no available treatments.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-Q - ZEVRA THERAPEUTICS, INC. (0001434647) (Filer) | 2026-05-06 | English | |
| DEF 14A - ZEVRA THERAPEUTICS, INC. (0001434647) (Filer) | 2026-04-20 | English | |
| 4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Issuer) | 2026-03-26 | English | |
| 4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Issuer) | 2026-03-19 | English | |
| 4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Filer) | 2026-02-10 | English | |
| 4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Filer) | 2026-02-04 | English |
Browse filings by year
18 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
13 filings
| |||||
| 42027237 | 10-Q - ZEVRA THERAPEUTICS, INC. (0001434647) (Filer) | 2026-05-06 | English | ||
| 34691421 | DEF 14A - ZEVRA THERAPEUTICS, INC. (0001434647) (Filer) | 2026-04-20 | English | ||
| 33048522 | 4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Issuer) | 2026-03-26 | English | ||
| 32989270 | 4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Issuer) | 2026-03-19 | English | ||
| 32891827 | 4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Filer) | 2026-02-10 | English | ||
| 32891826 | 4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Filer) | 2026-02-04 | English | ||
| 32891828 | 4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Filer) | 2026-02-04 | English | ||
| 29766128 | 4 Filing | 2026-02-02 | English | ||
| 29766101 | 4 Filing | 2026-02-02 | English | ||
| 29766096 | 4 Filing | 2026-02-02 | English | ||
| 29766080 | 4 Filing | 2026-02-02 | English | ||
| 29766031 | 4 Filing | 2026-02-02 | English | ||
| 12217933 | FORM 4 | 2026-01-07 | English | ||
|
2025
2 filings
| |||||
| 12217935 | 8-K | 2025-12-17 | English | ||
| 12217934 | FORM 4 | 2025-12-09 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Evolus, Inc.
A performance beauty company developing neurotoxins and der…
|
EOLS | US | Manufacturing |
|
EXACT Therapeutics AS
Clinical-stage biopharma using ultrasound to amplify the ef…
|
EXTX | NO | Manufacturing |
|
EXELIXIS, INC.
Oncology-focused biotech that discovers, develops, and comm…
|
EXEL | US | Manufacturing |
|
EXMceuticals Inc.
Pharmaceutical biosciences company supplying high-grade can…
|
— | CA | Manufacturing |
|
ExpreS2ion Biotech Holding AB
A clinical-stage biotech company developing vaccines for ca…
|
EXPRS2 | SE | Manufacturing |
|
Extrawell Pharmaceutical Holdings Limited
Manufactures proprietary pharmaceuticals and trades special…
|
858 | HK | Manufacturing |
|
EyePoint Pharmaceuticals, Inc.
Develops sustained drug delivery therapeutics for serious r…
|
EYPT | US | Manufacturing |
|
EZZ LIFE SCIENCE HOLDINGS LIMITED
Specializes in genomic research, health supplements, skinca…
|
EZZ | AU | Manufacturing |
|
Faes Farma S.A.
Researches, develops, and markets pharmaceuticals and anima…
|
FAE | ES | Manufacturing |
|
Fagron N.V.
A global pharmaceutical compounding company focused on pers…
|
FAGR | BE | Manufacturing |
ZEVRA THERAPEUTICS, INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32811/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32811 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32811 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32811 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32811}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ZEVRA THERAPEUTICS, INC. (id: 32811)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.